Stem cell transplantation for mantle cell lymphoma: should it ever be used outside clinical trials?SWEETENHAM, J. W.Bone marrow transplantation (Basingstoke). 2001, Vol 28, Num 9, pp 813-820, issn 0268-3369Article

COMPARISON OF IN VIVO AND IN VITRO BINDING OF POLYCYCLIC HYDROCARBONS TO DNAEASTMAN A; SWEETENHAM J; BRESNICK E et al.1978; CHEMICO BIOL. INTERACTIONS; NLD; DA. 1978; VOL. 23; NO 3; PP. 345-353; BIBL. 32 REF.Article

Isolation and culture of endothelial cells from human bone marrowMASEK, L. C; SWEETENHAM, J. W.British journal of haematology. 1994, Vol 88, Num 4, pp 855-865, issn 0007-1048Article

Are prophylactic haematopoietic growth factors of value in the management of patients with aggressive non-Hodgkin's lymphoma?HACKSHAW, A; SWEETENHAM, J; KNIGHT, A et al.British journal of cancer. 2004, Vol 90, Num 7, pp 1302-1305, issn 0007-0920, 4 p.Article

Haemopoietic progenitor homing and mobilizationTURNER, M. L; SWEETENHAM, J. W.British journal of haematology. 1996, Vol 94, Num 4, pp 592-596, issn 0007-1048Article

Urinary epidermal growth factor (hEGF) levels in patients with carcinomas of the breast, colon and rectumSWEETENHAM, J. .W; DAVIES, D. E; WARNES, S et al.British journal of cancer. 1990, Vol 62, Num 3, pp 459-461, issn 0007-0920, 3 p.Article

Adult lymphoblastic lymphoma : high incidence of central nervous system relapse in patients treated with the Stanford University protocolSWEETENHAM, J. W; MEAD, G. M; WHITEHOUSE, J. M. A et al.Annals of oncology. 1992, Vol 3, Num 10, pp 839-841, issn 0923-7534Article

Intensive weely combination chemotherapy for patients with intermediate-grade and high-grade non-Hodgkin's lymphomaSWEETENHAM, J. W; MEAD, G. M; WHITEHOUSE, J. M. A et al.Journal of clinical oncology. 1991, Vol 9, Num 12, pp 2202-2209, issn 0732-183XArticle

A single-centre study of treatment outcomes and survival in 120 patients with peripheral T-cell non-Hodgkin's lymphomaPELLATT, J; SWEETENHAM, J; PICKERING, R. M et al.Annals of hematology (Print). 2002, Vol 81, Num 5, pp 267-272, issn 0939-5555Article

High-dose therapy and autologous bone marrow transplantation for adult patients with lymphoblastic lymphoma : results of the European Group for bone marrow transplantationSWEETENHAM, J. W; LIBERTI, G; PEARCE, R et al.Journal of clinical oncology. 1994, Vol 12, Num 7, pp 1358-1365, issn 0732-183XArticle

Current therapies in Hodgkin's diseaseKOGEL, K. E; SWEETENHAM, J. W.European journal of nuclear medecine and molecular imaging Print. 2003, Vol 30, pp S19-S27, issn 1619-7070, SUP1Article

Involvement of the gastrointestinal tract by metastases from germ cell tumors of the testisSWEETENHAM, J. W; WHITEHOUSE, J. M; WILLIAMS, C. J et al.Cancer. 1988, Vol 61, Num 12, pp 2566-2570, issn 0008-543XArticle

Endothelial cell precursors are normal components of human umbilical cord bloodNIEDA, M; NICOL, A; DENNING-KENDALL, P et al.British journal of haematology. 1997, Vol 98, Num 3, pp 775-777, issn 0007-1048Article

Intestinal cryptosporidiosis: a complication of cancer treatmentMEAD, G. M; SWEETENHAM, J. W; EWINS, D. L et al.Cancer treatment reports. 1986, Vol 70, Num 6, pp 769-770, issn 0361-5960Article

Low-dose lenograstim is as effective as standard dose in shortening neutrophil engraftment time following myeloablative chemotherapy and peripheral blood progenitor cell rescueNOLAN, L; LORIGAN, P; CHILTON, S et al.British journal of haematology. 2007, Vol 137, Num 5, pp 436-442, issn 0007-1048, 7 p.Article

Cost-minimization analysis of CHOP, fludarabine and rituximab for the treatment of relapsed indolent B-cell non-Hodgkin's lymphoma in the U.KSWEETENHAM, J; HIEKE, K; KERRIGAN, M et al.British journal of haematology. 1999, Vol 106, Num 1, pp 47-54, issn 0007-1048Article

Analysis of V_H genes in follicular and diffuse lymphoma shows ongoing somatic mutation and multiple isotype transcripts in early disease with changes during disease progressionOTTENSMEIER, C. H; THOMPSETT, A. R; DELIN ZHU et al.Blood. 1998, Vol 91, Num 11, pp 4292-4299, issn 0006-4971Article

CAPE/PALE salvage chemotherapy for Hodgkin's disease patients relapsing within 1 year of ChIVPP chemotherapyFAIREY, A. F; MEAD, G. M; JONES, H. W et al.Annals of oncology. 1993, Vol 4, Num 10, pp 857-860, issn 0923-7534Article

ChlVPP chemotherapy in advanced Hodgkin's diseaseMCKENDRICK, J. J; MEAD, G. M; SWEETENHAM, J et al.European journal of cancer & clinical oncology. 1989, Vol 25, Num 3, pp 557-561, issn 0277-5379Article

Comparative adhesion of human haemopoietic cell lines to extracellular matrix components, bone marrow stromal and endothelial culturesTURNER, M. L; MASEK, L. C; HARDY, C. L et al.British journal of haematology. 1998, Vol 100, Num 1, pp 112-122, issn 0007-1048Article

Adult Burkitt's and Burkitt-like non-Hodgkin's lymphoma : Outcome for patients treated with high-dose therapy and autologous stem-cell transplantation in first remission or at relapse : Results from the European Group for blood and marrow transplantationSWEETENHAM, J. W; PEARCE, R; TAGHIPOUR, G et al.Journal of clinical oncology. 1996, Vol 14, Num 9, pp 2465-2472, issn 0732-183XArticle

Clinical features and management of malignant histiocytosis of the intestineMEAD, G. M; WHITEHOUSE, J. M; THOMPSON, J et al.Cancer. 1987, Vol 60, Num 11, pp 2791-2796, issn 0008-543XArticle

Expanded TcR Vβ5.1 family in a diffuse high-grade B cell immunoblastic lymphomaHODGES, E; SWINDELL, A; QUIN, C. T et al.Leukemia. 1995, Vol 9, Num 6, pp 1108-1112, issn 0887-6924Article

E-SHAP: inadequate treatment for poor-prognosis recurrent lymphomaJOHNSON, P. W. M; SWEETENHAM, J. W; MCCALLUM, P et al.Annals of oncology. 1993, Vol 4, Num 1, pp 63-67, issn 0923-7534Article

Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCTMICKELSON, D. M; SPROAT, L; COPELAN, E. A et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 1, pp 84-89, issn 0268-3369, 6 p.Article